Pressemitteilung 29.06.2016

Cendres+Métaux SA completes organizational set-up of the Luxe & Industry Division.

Cendres+Métaux SA concludes the organizational change of the CM Luxe & Industry Division started in March by presenting the new strategy and starting the implementation of the new organization. The continued currency issues and the intensified crisis in the watch industry require a fundamental realignment of the division's services. In this context, the capacity of the Jewellery Department will once more be adjusted.

The future activities will focus on the development of an extended range of services in terms of new technologies and materials. Thus, Cendres+Métaux SA will adapt to the changing needs of the watch industry in order to continue to be a competitive partner for major manufacturers. “We’re expecting that classic gold products such as oscillating weights will increasingly be demanded in other materials in the future," explains Marco Zingg, Chairman, Delegate and CEO of the CM Luxe & Industry Division. "For us this of course represents a structural change in the market, for which we are well prepared, though, by our very broad technological set-up."

The Jewellery Department, which is part of the CM Luxe & Industry Division, as well experiences a profound structural change. The continued currency issues have led to a sharp decline in contract manufacturing orders. In addition, customers have shifted manufacturing processes consistently to neighboring countries. The management of Cendres+Métaux SA estimates that this is not just a short-term trend and has therefore decided to adjust the organizational and personnel structures to the new market situation. The personnel measures associated will be cushioned by a social plan that was agreed on with the social partners.

However, the realignment of the CM Medtech Division about a year ago shows first successes. "With the new positioning, we were able to improve the organization's performance significantly”, says Arne Faisst, Member of the Board of Directors and CEO of CM Medtech. "We are currently working on a series of innovative new products that we will introduce in various markets, starting next year." The focus thereby lies on Europe and Asia. It is imperative to strengthen our own subsidiaries and long-term partners with an expanded range of products to support their sales performance in the market.


Marco Zingg
President of the Board
Delegate of the Board of Directors
Dr. Arne-Christian Faisst
CEO Medtech
Member of the Board of Directors

29 June 2016

« Back to overview